Millipore Sigma Vibrant Logo

343290 Fluoxetine, Hydrochloride - CAS 56296-78-7 - Calbiochem

A cell-permeable phenylpropylamine derived anti-depressant that acts as a selective serotonin re-uptake inhibitor (SSRI).

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: dl-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine, HCl, (±)-N-Methyl-3-phenyl-3-[(α,α,α-trifluoro-p-tolyl)oxy]propylamine, HCl, LY-110140, Prozac

Primary Target: Selective serotonin re-uptake inhibitor
View Products on Sigmaaldrich.com
343290
가격 및 재고 조회

개요

Replacement Information

주요 사양표

CAS #Empirical Formula
56296-78-7C₁₇H₁₈F₃NO • HCL

가격 및 재고여부

카탈로그 번호 재고 정보패킹 포장 단위 가격(VAT 별도) 수량
343290-25MGCN
재고 정보 검색...
—
현재 재고 없음 현재 재고 없음
예상 출고 가능일 
단종품
제한된 수량 가능
재고여부 확인
    Remaining: will advise
      Remaining: will advise
      추천사항
      고객 서비스로 문의
      Contact Customer Service

      		 Plastic ampoule 25 mg
      가격 검색...
      가격을 검색할 수 없습니다
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      가격 문의 추가 정보
      ()이 할인됨
       
      —
      가격 문의
      		 —
      Description
      OverviewA cell-permeable phenylpropylamine derived anti-depressant that acts as a selective serotonin re-uptake inhibitor (SSRI). Reported to modulate the proliferation of T-cells by increasing the Ca2+ influx and thereby influencing the activities of protein kinase A (PKA) and protein kinase C (PKC). Also shown to regulate the phosphorylation of DARPP-32 (dopamine-and cAMP-regulated phosphoprotein of Mr 32,000) and AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors. Shown to trigger oxidative stress-induced apoptotic cell death. Also reported to initiate signaling pathways in neuronal cells leading to activation of ERK and NF-κB.
      Catalogue Number343290
      Brand Family Calbiochem®
      Synonymsdl-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine, HCl, (±)-N-Methyl-3-phenyl-3-[(α,α,α-trifluoro-p-tolyl)oxy]propylamine, HCl, LY-110140, Prozac
      References
      ReferencesBartholoma, P., et al. 2002. Biochem. Pharmacol. 63, 1507.
      Bian, J.T., et al. 2002. Eur. J. Pharmacol. 453, 159.
      Zhang, A., et al. 2002. J. Med. Chem. 45, 1930.
      Svenningsson, P., et al. 2002. Proc. Natl. Acad. Sci. USA 99, 3182.
      Edgar, V.A., et al. 1999. Eur. J. Pharmacol. 372, 65.
      Product Information
      CAS number56296-78-7
      ATP CompetitiveN
      FormSolid
      Hill FormulaC₁₇H₁₈F₃NO • HCL
      Chemical formulaC₁₇H₁₈F₃NO • HCL
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetSelective serotonin re-uptake inhibitor
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      카탈로그 번호 GTIN
      343290-25MGCN 04055977195101

      Documentation

      Fluoxetine, Hydrochloride - CAS 56296-78-7 - Calbiochem MSDS

      타이틀

      물질안전보건자료(MSDS) 

      Fluoxetine, Hydrochloride - CAS 56296-78-7 - Calbiochem Certificates of Analysis

      TitleLot Number
      343290

      References

      참고문헌 보기
      Bartholoma, P., et al. 2002. Biochem. Pharmacol. 63, 1507.
      Bian, J.T., et al. 2002. Eur. J. Pharmacol. 453, 159.
      Zhang, A., et al. 2002. J. Med. Chem. 45, 1930.
      Svenningsson, P., et al. 2002. Proc. Natl. Acad. Sci. USA 99, 3182.
      Edgar, V.A., et al. 1999. Eur. J. Pharmacol. 372, 65.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision05-July-2017 JSW
      Synonymsdl-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine, HCl, (±)-N-Methyl-3-phenyl-3-[(α,α,α-trifluoro-p-tolyl)oxy]propylamine, HCl, LY-110140, Prozac
      DescriptionA cell-permeable phenylpropylamine derived anti-depressant that acts as a selective serotonin re-uptake inhibitor (SSRI). Reported to modulate the proliferation of T cells by increasing the Ca2+ influx thereby influencing the activities of protein kinase A (PKA) and protein kinase C (PKC). Inhibits leak K+ currents in a reversible and voltage-independent manner (IC50 = 780 nM). Also shown to regulate the phosphorylation of DARPP-32 (dopamine-and cAMP-regulated phosphoprotein of Mr 32,000) and AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors. Triggers oxidative stress-induced apoptotic cell death and initiates signaling pathways in neuronal cells leading to an activation of ERK and NF-κB.
      FormSolid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number56296-78-7
      Chemical formulaC₁₇H₁₈F₃NO • HCL
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityH₂O (5 mg/ml) or Methanol (100 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Harmful
      Merck USA index14, 4185
      ReferencesBartholoma, P., et al. 2002. Biochem. Pharmacol. 63, 1507.
      Bian, J.T., et al. 2002. Eur. J. Pharmacol. 453, 159.
      Zhang, A., et al. 2002. J. Med. Chem. 45, 1930.
      Svenningsson, P., et al. 2002. Proc. Natl. Acad. Sci. USA 99, 3182.
      Edgar, V.A., et al. 1999. Eur. J. Pharmacol. 372, 65.